arrow
C

Corey Cutler

Harvard Medical School
H指数:104
被引数:4.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Venetoclax-augmented RIC allogeneic HCT with PTCy-based GVHD prophylaxis and venetoclax/azacitidine maintenance for poor risk MDS and AML

维奈克拉增强的RIC同种异基因HCT联合PTCy为基础的GVHD预防及维奈克拉/阿扎胞苷维持治疗高危MDS和AML

2026-08-190
OAAI
A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Ib期研究:重组人白介素-22受体激动剂efmarodocokin alfa联合标准治疗方案在异基因造血干细胞移植患者中的应用

2026-06-010
OAAI
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AML

Venetoclax/FluBu2 缓和性化疗移植后,采用全口服 venetoclax/decitabine 维持治疗高危 MDS/AML

2025-12-090
OAAI
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse

自造血干细胞移植(HCT)后复发急性髓系白血病(AML)并达到缓解的患者,细胞疗法巩固治疗并无明确益处。

2025-11-040
OAAI
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study

异基因造血干细胞移植在青少年和年轻急性淋巴细胞白血病患者中的应用——一项回顾性、双中心研究

2025-10-010
OAAI
Expression of HLA-B*35 is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-based Hematopoietic Cell Transplantation

HLA-B*35的表达与PTCy-based造血细胞移植后巨细胞病毒(CMV)病毒血症及临床显著CMV感染风险的增加相关。

2025-09-210
PRE
Out-of-Pocket Expenditures and Financial Hardship Among Patients With Myelodysplastic Syndrome Undergoing Allogeneic Transplant or Hypomethylating Agent / Supportive Care (BMT CTN 1102)

自付支出与骨髓增生异常综合征患者接受同种异体移植或低甲基化药物/支持性护理治疗时的财务困难(BMT CTN 1102)

2025-07-010
PRE
A Structured Peer Support Intervention for Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation: Peer Support Interventionists’ Perspectives

针对接受造血干细胞移植的血液恶性肿瘤患者的结构化同伴支持干预:同伴支持干预者的视角

2025-06-010
PRE
Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study

贝卢莫苏迪尔减轻口腔慢性移植物抗宿主病组织炎症和纤维化:一项ROCKstar伴侶研究

2025-05-050
OA
Caregiver experiences managing information prior to hematopoietic stem cell transplantation and after transition to home: a qualitative study

照护者在造血干细胞移植前及转归家庭后的信息管理经历:一项定性研究

2025-04-220
PRE
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome

ASTCT和USCLC关于在皮肤T细胞淋巴瘤(mycosis fungoides和Sézary综合征)中异基因干细胞移植的临床实践建议

2025-04-060
PRE
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant CyclophosphamideBased Graft-Versus-Host Disease Prophylaxis

供体类型不影响低强度异基因造血细胞移植后的晚期移植失败,移植后基于环磷酰胺的移植物抗宿主病预防

2025-03-010
PRE
A Peer Support Intervention in Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation (HSCT): The STEPP Proof-of-Concept Trial

接受造血干细胞移植 (HSCT) 的血液系统恶性肿瘤患者的同伴支持干预: STEPP概念验证试验

2024-12-011
PRE